BioSpace News Archive

As Americans brace themselves for year three of pandemic life, their mental health hits an all-time low, according to the Mental Health Index: U.S. Worker Edition. Most notably, PTSD, depression and addiction soar amid skyrocketing cases of Omicron.

Suvoda, LLC, a global clinical trial technology company that specializes in highly complex studies, such as oncology, central nervous system and rare disease, announced that 2021 was another record year, exceeding its bookings targets and expanding its reach by supporting complex clinical trials in 65 countries.

TriSalus Life Sciences®, an immunotherapy company on a mission to extend and improve the lives of patients living with liver and pancreatic tumors, today announced a strategic research collaboration with the University of Colorado Anschutz Medical Campus to advance research of immuno-oncology treatments for patients with liver and pancreatic tumors.

Viewpoint Molecular Targeting, Inc., a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents, announced that Frances L. Johnson, MD, Chief Executive Officer will participate in the Virtual Investor 2022 Top Picks Conference on Tuesday, January 25, 2022 at 11:00 AM ET.

New updates to the National Standards for Diabetes Self-Management Education and Support call for addressing health equity by improving access to diabetes self-management education and support services, a renewed focus on increasing and maintaining person-centered care and reducing administrative burden.

The Midwest Bioprocessing Center (MBC), a leading producer of bio-based chemicals for human health and nutrition, announced that it has been award a $1.87MM grant from the National Institutes of Health to develop a variety of new monosaccharides, oligosaccharides, and glycans needed for the study of viral glycobiology and development of new antiviral drugs.

Increasing R&D expenditure by pharmaceutical and biotechnology companies and development of cell therapy industry are expected drive market growth.

The San Francisco Bay Area is the world leader in Life Science. Vacaville has been successful at attracting top biotech companies, including Genentech and just recently the Boston-based Agenus.

Medline today announced that it has been awarded a five-year cooperative agreement with OMNIA Partners, one of the nation’s largest purchasing organizations for public and private sector procurement. In effect as of November 1, 2021, the publicly solicited contract is available nationwide.

Eargo, Inc., a medical device company on a mission to improve the quality of life of people with hearing loss, announced the submission of public comments to the Food and Drug Administration concerning its proposed rule to create a new regulatory category of over the counter hearing aids.